SAGE - Sage Therapeutic - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SAGE is currently covered by 21 analysts with an average price target of $26.37. This is a potential upside of $17.1 (184.47%) from yesterday's end of day stock price of $9.27.

Sage Therapeutic's activity chart (see below) currently has 397 price targets and 381 ratings on display. The stock rating distribution of SAGE is 17.27% BUY, 78.18% HOLD and 4.55% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 48.97% with an average time for these price targets to be met of 153.19 days.

Highest price target for SAGE is $26, Lowest price target is $5, average price target is $10.98.

Most recent stock forecast was given by GEORGE FARMER from SCOTIABANK on 08-Jul-2025. First documented stock forecast 12-Aug-2014.

Currently out of the existing stock ratings of SAGE, 19 are a BUY (17.27%), 86 are a HOLD (78.18%), 5 are a SELL (4.55%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$9.2

$-0.07 (-0.76%)

$12

5 days ago
(08-Jul-2025)

2/9 (22.22%)

$0.04 (0.44%)

31

Hold

$9

$-0.27 (-2.91%)

$9

23 days ago
(20-Jun-2025)

1/5 (20%)

$-0.3 (-3.23%)

250

Hold

$12

$2.73 (29.45%)

$12

26 days ago
(17-Jun-2025)

9/23 (39.13%)

$2.88 (31.58%)

172

Hold

$8.5

$-0.77 (-8.31%)

$8

26 days ago
(17-Jun-2025)

4/12 (33.33%)

$-0.62 (-6.80%)

168

Hold

27 days ago
(16-Jun-2025)

0/8 (0%)

$53.25 (317.91%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SAGE (Sage Therapeutic) average time for price targets to be met?

On average it took 153.19 days on average for the stock forecasts to be realized with a an average price target met ratio 48.97

Which analyst has the current highest performing score on SAGE (Sage Therapeutic) with a proven track record?

JOHN NEWMAN

Which analyst has the most public recommendations on SAGE (Sage Therapeutic)?

John Newman works at CANACCORD and has 5 price targets and 4 ratings on SAGE

Which analyst is the currently most bullish on SAGE (Sage Therapeutic)?

Gbola Amusa with highest potential upside - $215.73

Which analyst is the currently most reserved on SAGE (Sage Therapeutic)?

Brian Abrahams with lowest potential downside - -$4.27

Sage Therapeutic in the News

Scotiabank downgrades Sage Therapeutics stock rating to Sector Perform

Investing.com – Scotiabank (TSX:BNS) downgraded Sage Therapeutics (NASDAQ:SAGE) from Sector Outperform to Sector Perform on Tuesday, while lowering its price target to $9.20 from $12.00. The stock, currently trading at $9.17, has shown remarkable strength with a 56.75% gain over the past six months, though InvestingPro data indicates the shares may be overbought at current...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?